MedPath

EPOKINE

Brand Name: EPOKINE

Generic Name: EPOETIN ALFA (RECOMBINANT HUMAN ERYTHROPOIETIN)

Active
Registration Number

BRP-104

Dosage Form

SOLUTION FOR INJECTION (IV/SC)

Issuance Date

July 8, 2022

Expiry Date

July 25, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength2,000 IU/ 0.5 mL
Packaging0.5 mL Pre-filled Glass Syringe (Box of 6's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
HEMATOPOIETIC GROWTH FACTOR
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

EPOETIN ALFA (RECOMBINANT HUMAN ERYTHROPOIETIN)Active
Monograph: epoetin alfa (recombinant human erythropoietin)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.